Display options
Share it on

Children (Basel). 2021 Oct 22;8(11). doi: 10.3390/children8110950.

Optimization of Personalized Amlodipine Dosing Strategies for Children Based on Pharmacokinetic Data from Chinese Male Adults and PBPK Modeling.

Children (Basel, Switzerland)

Xiaolu Han, Xiaoxuan Hong, Xianfu Li, Yuxi Wang, Zengming Wang, Aiping Zheng

Affiliations

  1. State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, 27th Taiping Road, Haidian District, Beijing 100850, China.
  2. Troops 32104 of People's Liberation Army of China, Alashan League 735400, China.
  3. Shanghai PharmoGo Co., Ltd., 3F, Block B, Weitai Building, No. 58, Lane 91, Shanghai 200127, China.

PMID: 34828663 PMCID: PMC8618961 DOI: 10.3390/children8110950

Abstract

For children, a special population who are continuously developing, a reasonable dosing strategy is the key to clinical therapy. Accurate dose predictions can help maximize efficacy and minimize pain in pediatrics.

Keywords: PBPK model; amlodipine; dosage optimization; hypertension; model-informed drug development; pediatric preparations

References

  1. J Pharm Sci. 2019 Aug;108(8):2781-2790 - PubMed
  2. Curr Hypertens Rep. 2019 Apr 5;21(5):35 - PubMed
  3. J Hypertens. 2009 Sep;27(9):1719-42 - PubMed
  4. J Am Pharm Assoc (Wash). 2002 Jan-Feb;42(1):114-7 - PubMed
  5. Eur J Pediatr. 1998 Aug;157(8):618-21 - PubMed
  6. Am J Hypertens. 2000 Oct;13(10):1061-6 - PubMed
  7. Drug Metab Dispos. 1980 Sep-Oct;8(5):343-8 - PubMed
  8. Drugs. 1991 Mar;41(3):478-505 - PubMed
  9. Clin Pharmacol Ther. 2012 Jul;92(1):40-9 - PubMed
  10. Clin Pharmacokinet. 2013 Jun;52(6):415-31 - PubMed
  11. AAPS J. 2009 Mar;11(1):155-66 - PubMed
  12. Acta Pharmacol Sin. 2012 Nov;33(11):1359-71 - PubMed
  13. J Clin Pharmacol. 2006 Aug;46(8):905-16 - PubMed
  14. Am J Hosp Pharm. 1994 Jan 1;51(1):59-68 - PubMed
  15. Pediatr Clin North Am. 1987 Jun;34(3):571-90 - PubMed
  16. J Emerg Med. 2010 Aug;39(2):186-93 - PubMed
  17. Pediatr Nephrol. 2005 May;20(5):631-5 - PubMed
  18. Pediatr Nephrol. 2000 Dec;15(3-4):302-16 - PubMed
  19. AAPS J. 2020 Aug 10;22(5):107 - PubMed
  20. Postgrad Med J. 1991;67 Suppl 3:S20-3 - PubMed
  21. J Pharm Pharm Sci. 2006;9(2):169-89 - PubMed
  22. Pharm Res. 2008 Aug;25(8):1891-901 - PubMed
  23. AAPS J. 2016 Nov;18(6):1453-1463 - PubMed
  24. Clin Pharmacokinet. 1992 Jan;22(1):22-31 - PubMed
  25. N Engl J Med. 2003 Sep 18;349(12):1157-67 - PubMed
  26. Pharm Res. 2019 Oct 25;36(12):171 - PubMed
  27. J Clin Hypertens (Greenwich). 2010 Jan;12(1):34-9 - PubMed
  28. Pediatrics. 1996 Oct;98(4 Pt 1):649-58 - PubMed
  29. J Pharm Sci. 2007 Jun;96(6):1638-52 - PubMed
  30. Adv Drug Deliv Rev. 2001 Oct 1;50 Suppl 1:S41-67 - PubMed
  31. Pediatr Nephrol. 1999 May;13(4):304-10 - PubMed
  32. Clin Pharmacokinet. 2011 Sep;50(9):613-23 - PubMed
  33. J Cardiovasc Pharmacol. 1988;12 Suppl 7:S55-9 - PubMed
  34. Pediatr Radiol. 1997 Mar;27(3):250-2 - PubMed
  35. J Pharmacokinet Pharmacodyn. 2018 Jun;45(3):443-456 - PubMed
  36. Br J Clin Pharmacol. 1986 Jul;22(1):21-5 - PubMed
  37. Clin Pharmacol Ther. 2013 Feb;93(2):149 - PubMed

Publication Types

Grant support